HomeCompaniesNephrogen

Nephrogen

Curative gene therapies for kidney diseases

Nephrogen is a biotech company developing curative gene therapies for kidney and pancreatic diseases. Kidney disease affects 1 in 7 Americans (~50 million people), has no cure, and accounts for nearly 10% of the Medicare budget.
Active Founders
Demetri Maxim
Demetri Maxim
Founder
Stanford B.S. '20 (Biology), Founder of Nephrogen
Nephrogen
Founded:2022
Batch:Summer 2020
Team Size:1
Status:
Active
Location:New York
Primary Partner:Jared Friedman